Calyxt founder Dan Voytas is applying editing methods for non-GMO crop improvements.
Health Care + Med Tech
Study says consumers pay as much as 13% less for narrow-network plans.
Eagan firm seeks Nasdaq hearing.
The health tech platform will uses population-level clinical data to provide caregivers with solutions to trim costs and impact efficiency and quality of care.
Terms of the three-year contract include compensation toward health care-related costs, a 2 percent annual wage increase and all-day security protection in emergency rooms.
Both businesses work to reduce costs and control efficiency of a worker’s return to their job after a time of injury.
The gene editing company is known for its proprietary pig models, which are used in treatment studies for cancer, heart disease, diabetes and other conditions.
Once completed, Douglas County Hospital will have more than 33,000 square-feet of newly created or revamped space in its surgery center.
MN-REACH grant moves cellular-level tumor probe closer to market.
This is the medical device maker’s second major recall this year.
A majority of nurses felt the latest contract offer from Allina “took away more from nurses than it offered.”
Commercial health plans in state score well on annual NCQA ratings report.
Close ties cited between Chrono Therapeutics, Mayo’s Nicotine Dependence Center.
Colorectal cancer test’s epic journey to market a case study for innovation.
Company’s catheter stabilizing product has drawn previous investment.
The medtech company will buy EndoChoice for $8 a share, a roughly 90 percent premium from the gastroenterology company’s Monday close of $4.22 a share.
The university was named a Udall Center of Excellence in Parkinson’s Disease Research, and also earned the right to open a prestigious Udall Center on its campus.
A focus on technology transfer at Mayo’s Transform 2016 conference.